Zevra Therapeutics (ZVRA) Net Margin (2019 - 2026)
Zevra Therapeutics' Net Margin was 22.05% in Q2 2026, down 266.40 percentage points from 288.44% a year earlier and down 82.57 percentage points from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Net Margin (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Zevra Therapeutics' Net Margin was 42.79% through Jun 30, 2026, up 38.52 percentage points year-over-year; for FY2025, it was 78.15%, up 525.00 percentage points from FY2024.
- Net Margin shows a five-year change of +174.18 percentage points (FY2020 to FY2025).
- In earlier years, Net Margin was -446.85% in FY2024 (-279.16 pp), -167.69% in FY2023 (+241.16 pp), -408.85% in FY2022 (-189.31 pp) and -219.54% in FY2021 (-123.51 pp).
- Quarterly Net Margin has moved between -1849.38% (Q2 2022) and 288.44% (Q2 2025) over five years.
- Compared with a year earlier, Net Margin was higher in five of the last eight quarters, with an average year-over-year change of +200.64 percentage points.
- The best year-over-year quarter for Net Margin over five years was Q2 2023 (a gain of 1819.01 percentage points); the worst was Q2 2022 (a drop of 1760.16 percentage points).
- Per Business Quant data, ZVRA's Net Margin in the three quarters before Q2 2026 was 104.61% (Q1 2026), 35.62% (Q4 2025) and -2.08% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 32.99% |
| 10 | Zevra Therapeutics | 650.98 Mn | -161.73 Mn | 38.18 Mn | 22.05% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.05% |
| Mar 31, 2026 | 104.61% |
| Dec 31, 2025 | 35.62% |
| Sep 30, 2025 | -2.08% |
| Jun 30, 2025 | 288.44% |
| Mar 31, 2025 | -15.19% |
| Dec 31, 2024 | -297.53% |
| Sep 30, 2024 | -897.97% |
| Jun 30, 2024 | -447.85% |
| Mar 31, 2024 | -485.31% |
| Dec 31, 2023 | -153.63% |
| Sep 30, 2023 | -358.10% |
| Jun 30, 2023 | -30.38% |
| Mar 31, 2023 | -370.50% |
| Dec 31, 2022 | -446.14% |
| Sep 30, 2022 | -230.20% |
| Jun 30, 2022 | -1,849.38% |
| Mar 31, 2022 | -47.01% |
| Dec 31, 2021 | -104.69% |
| Sep 30, 2021 | -89.52% |
API Access
Zevra Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();